Teradyne director Marilyn Matz sells $140,444 in shares
Teradyne director Marilyn Matz sold 400 shares for $140,444 at $351.11 each on September 17, 2026. Teradyne's stock has risen to $361.30, with a 198% return over the past year. The company reported Q2 non-GAAP earnings of $2.47 per share on revenue of $1.33 billion, exceeding expectations. Baird downgraded Teradyne to Neutral due to valuation concerns.
How this was made
The 30-second read
Why it matters
For trading, the actionable signal is mainly the insider transaction disclosure plus the valuation/catalyst framing from the downgrade; the earnings numbers cited appear as already-reported context rather than a fresh guidance print in this article.
Market read
Traders may treat this as minor sentiment noise around a strong recent stock run, while the more decision-relevant item is the valuation/catalyst caution highlighted by the downgrade.
What to watch
The article also references a Baird downgrade tied to valuation and catalyst uncertainty, which may matter more for positioning than the director’s sale itself.
Background
The piece combines a director Form 4-style insider sale (Rule 10b5-1) with a recap of Teradyne’s recent earnings beat and an analyst downgrade.
Ticker impact
Teradyne director Marilyn Matz sold 400 shares for $140,444 on Sep 17, 2026 under a Rule 10b5-1 plan, after the stock rose.
Near-term impact likely limited; any reaction would be more sentiment-driven than fundamentals.
The article frames the sale as Rule 10b5-1 and provides no new company-specific operational change tied to the transaction. It also mentions prior earnings strength and a Baird downgrade, which are more relevant to valuation than the sale itself.
Market effects
AI/data-center demand narrative remains supportive for industrial automation and test equipment, but valuation concerns are resurfacing via analyst commentary.
No direct regional transmission beyond general US market tone described in the wrap.
Limited; the disclosed event is company-specific and US-listed.
Counterpoint
Because the sale is executed under a pre-set Rule 10b5-1 plan, it may not signal bearish expectations; traders may overreact to the headline.
Key entities
- public_companyTeradyne, Inc.
NASDAQ-listed test equipment company; subject of the director sale and referenced earnings beat/downgrade.
- insiderMarilyn Matz
Teradyne director who sold 400 shares for $140,444 on Sep 17, 2026 under a Rule 10b5-1 plan.
- analyst_firmBaird
Issued a downgrade from Outperform to Neutral citing valuation and lack of near-term catalysts.
